AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo
BSE753.80-3.45 (-0.46 %)
PREV CLOSE ( ) 757.25
OPEN PRICE ( ) 757.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 22518
TODAY'S LOW / HIGH ( )749.25 760.45
52 WK LOW / HIGH ( )504 833.4
NSE754.05-1.95 (-0.26 %)
PREV CLOSE( ) 756.00
OPEN PRICE ( ) 757.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 242818
TODAY'S LOW / HIGH( ) 750.05 760.90
52 WK LOW / HIGH ( )503.05 833.05
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 26-12 1986
Management Info
K Ragunathan - Chairman N Govindarajan - Managing Director
Registered Office

Address Plot No. 2,Maitrivihar ,Ameerpet,
Hyderabad,
Telangana-500038

Phone +91-040-66725000

Email info@aurobindo.com

Website www.aurobindo.com

Registrars Details
Karvy Computershare Pvt Ltd
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
17Oct Aurobindo Pharma gets USFDA's approval
Aurobindo Pharma has received final approval from the US Food & Drug..
17Oct Aurobindo Pharma gets USFDA's approval
Aurobindo Pharma has received final approval from the US Food & Drug..
17Oct Aurobindo Pharma surges on getting USF
Aurobindo Pharma is currently trading at Rs. 770.10, up by 12.50 points..
26Sep Aurobindo Pharma trades higher on the
Aurobindo Pharma is currently trading at Rs. 708.40, up by 5.85 points o..
30Aug Aurobindo Pharma in talks with Shreya
Aurobindo Pharma is reportedly in discussion with Shreya Life Sciences f..
Financials
Rs. in Millions
QTR Jun 17 ANNUAL 17
Net Profit3073.317067.6
Gross Profit 4066.2 21785.7
Operating Profit 5002.625099
Net Sales 21882.997812.1
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 4207.05 (1.20%)
M.Cap (Rs. in Cr)8939.69
Merck (BSE)
 1170.30 (2.35%)
M.Cap (Rs. in Cr)1942.63
NGL Fine-Chem (BSE)
 375.20 (4.98%)
M.Cap (Rs. in Cr)231.80
Piramal Enterprises (BSE)
 2773.60 (0.64%)
M.Cap (Rs. in Cr)47862.10
Smruthi Organics (BSE)
 102.15 (19.68%)
M.Cap (Rs. in Cr)38.97
Shareholding Pattern
PROMOTERS 51.87%
MUTUAL FUNDS/UTI 14.89%
NON-INSTITUTION 13.98%
FI/BANKS/INSURANCE 0.46%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYC
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912

INVESTOR PROTECTION

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.